Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2007-07-17

FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

FDA approved a supplemental application for ZEMPLAR (paricalcitol) from AbbVie, resulting in changes to the product labeling. Paricalcitol is used to treat seco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zemplar (Paricalcitol)

Snippet

SUPPL AP for ZEMPLAR (PARICALCITOL)